Navigation Links
Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
Date:3/10/2011

nted at the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA) in October 2010. Clinical investigator Derrick Crook, M.D., presented data showing that CDI patients treated with fidaxomicin experienced 47% fewer recurrences than patients treated with vancomycin.
  • Five abstracts from Optimer's fidaxomicin Phase 3 studies in patients with CDI were presented at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in September 2010. Data from these abstracts highlighted that fidaxomicin was shown to be superior to vancomycin in treating CDI recurrences and reducing the chance of another relapse. Other conference presentations highlighted data showing that for patients taking concomitant antibiotics, fidaxomicin was a superior therapy to vancomycin in preventing recurrence and promoting global cure.
  • Entered into a long-term supply agreement with Biocon Limited for the commercial manufacture of the active pharmaceutical ingredient in fidaxomicin.
  • Pedro Lichtinger succeeded Michael N. Chang, Ph.D. as Optimer's President and Chief Executive Officer and also was appointed to the Board of Directors.  Dr. Chang was appointed Chairman of Optimer's Board of Directors. 
  • Top-line data from Optimer's second Phase 3 study of fidaxomicin was presented for the first time by clinical investigator, Derrick Crook, M.D., at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting in April 2010. Dr. Crook also presented additional data on the strain type subgroups BI/NAP1/027 and non-BI/NAP1/027 which showed fidaxomicin had a clinically meaningful reduction in recurrence rates and higher global cure rates compared to vancomycin in both these subgroups. 
  • Announced positive results from the second Phase 3 trial of fidaxomicin in CDI confirming the results of our first Phase 3 trial. 91.7% of patients treated with fidaxomicin (per protocol population) achiev
    '/>"/>

  • SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
    2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
    3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
    4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
    5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
    6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
    7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
    8. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
    9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
    10. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
    11. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/20/2014)... , Aug. 20, 2014 ... research report is available in its ... Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing ... http://www.reportlinker.com/p01618925/The-Market-for-Hospital-Acquired-Infection-Control-Sterilization-Disinfection-Testing-and-Treatment.html Given the ... (HAIs), demand has increased for solutions ...
    (Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: The Impact of Healthcare Reform ... http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html The "Patient ... complex legislation that affects virtually every aspect of ... beginning to take effect now. IVD manufacturers who ...
    (Date:8/20/2014)... 2014 Reportlinker.com announces that a ... its catalogue: Personal Accident and ... Opportunities to 2018 ... provides in depth market analysis, information and ... health insurance segment, including: - The French ...
    Breaking Medicine Technology:The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 3The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 4The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 5The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 6The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 3Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 4Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 5Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 7Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 8Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 9Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 10Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 11Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 12Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 13Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 14Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 15Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 16Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 17Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 18Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 19Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 20Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 21Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 22Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 23
    ... 28 Danaher Corporation (NYSE: DHR ) announced ... Comas will be presenting at the Goldman Sachs Global Industrials ... at 10:15 a.m. EDT. The company also announced that President ... presenting at the Robert W. Baird Industrial Conference in Chicago, ...
    ... The U.S. Food and Drug Administration today ... of adults with schizophrenia. (Logo: ... ) Schizophrenia affects about 1 ... and older, in a given year. The most ...
    Cached Medicine Technology:FDA Approves Latuda to Treat Schizophrenia in Adults 2
    (Date:8/20/2014)... August 20, 2014 Biocide Systems ... on Wrench Advisors as a consultant and partner ... large accounts. , As Wrench Advisors explains on ... help your organization plan and execute programs by ... distribution channels. Our experience developing joint venture partnerships ...
    (Date:8/20/2014)... TX (PRWEB) August 20, 2014 The ... Surgery (ACPS), has expanded its presence throughout Houston to ... Mann Eye Institute and Laser Center building. ACPS plastic ... natural step forward for ACPS, which has risen to ... plastic surgery practices in the state since its establishment ...
    (Date:8/20/2014)... Aug. 20, 2014 (HealthDay News) -- White, straight women ... than minority, bisexual or lesbian women, a new study ... American women, aged 21 to 44, who took part ... of the National Survey of Family Growth study. ... women said they sought treatment for infertility. This ranged ...
    (Date:8/20/2014)... receiving mental health services from the Veterans Health Administration ... among all areas studied. , The RAND Corporation study, ... a substance use disorder were less satisfied than other ... abuse problems also were less likely than others to ... decisions. , The findings, published in the journal ...
    (Date:8/20/2014)... predict both breast cancer relapses and responses to ... The newly found marker could help doctors classify ... regimen that is more effective. The discovery was ... of Molecular and Cell Biology (IMCB), and the ... the National University of Singapore (NUS). , Despite ...
    Breaking Medicine News(10 mins):Health News:Biocide Systems Announces Partnership with Wrench Advisors 2Health News:Aesthetic Center for Plastic Surgery Expands Its Reach in Texas 2Health News:White Women More Likely to Seek Fertility Treatment: Report 2Health News:Survey finds veterans generally satisfied with mental health care 2Health News:Novel gene predicts both breast cancer relapse and response to chemotherapy 2
    ... of winning a battle with cancer, as opposed to adults, ... years ago.// A recent report has explained that despite ... absolve them from the risks of long-term health problems in ... Childhood Cancer Survivor Study is a long-standing pioneer in the ...
    ... patients with severe psoriasis, appear to be at increased ... in the October 11 issue of JAMA.// ,Psoriasis ... percent to 3 percent of the adult population. It ... increased C-reactive protein levels, which have been linked to ...
    ... Kankova and colleagues from the Departments of Parasitology, Microbiology ... and GynCentrum, in the Czech Republic, women with dormant ... who are Toxoplasma negative. // ,Toxoplasma gondii ... with a universal occurrence of 20-80%. This study is ...
    ... for answers, but when it comes to cancer, physicians ... cancers. While certain tests can indicate the possibility of ... to monitor patients for cancer currently is not available ... University of Virginia School of Medicine are out to ...
    ... Parents with allergic symptoms like wheezing, asthma, hay ... to their infants too, according to a study by ... practice of avoiding skin testing for airborne allergens before ... in this high-risk group can be detected early and ...
    ... dengue death was reported in the capital, taking the toll ... city hospitals.// ,The total number of dengue cases in ... victim of the mosquito-borne viral disease was 25-year-old Farahan of ... Medical Science (AIIMS) here Friday and died in the early ...
    Cached Medicine News:Health News:Childhood Cancer Survivors May Suffer Health Problems in Adulthood 2Health News:Psoriasis Associated With Increased Risk For Heart Attack 2Health News:Effect of parasitic infection on baby's sex 2Health News:Researchers Developing Office-Based Cancer Screening Test 2Health News:Allergy Sufferers Pass on Allergies to their Children 2Health News:Dengue Claims Yet Another Victim in Delhi 2
    Manual Lensmeter....
    Lightweight, cordless lensmeter....
    Lightweight, cordless lensmeter....
    ... 101 is well suited for measuring ... well as conventional spectacle lenses. It ... a full 90-degree inclination, which facilitates ... used in the vertical position. The ...
    Medicine Products: